We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+9.81%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81B
AUM Growth
+$6.66B
Cap. Flow
+$1.82B
Cap. Flow %
2.24%
Top 10 Hldgs %
22.31%
Holding
3,027
New
17
Increased
2,329
Reduced
595
Closed
62

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$164M
2
MSFT icon
Microsoft
MSFT
+$157M
3
AMZN icon
Amazon
AMZN
+$75.7M
4
TSLA icon
Tesla
TSLA
+$50M
5
GEHC icon
GE HealthCare
GEHC
+$45.2M

Sector Composition

Rank Sector Weight
1 Technology 25.37%
2 Healthcare 13.58%
3 Financials 12.66%
4 Consumer Discretionary 10.75%
5 Industrials 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KOD icon
2576
Kodiak Sciences
KOD
$2.84B
$339K ﹤0.01%
54,684
+1,128
+2% +$7.89K
MVBF icon
2577
MVB Financial
MVBF
$389M
$335K ﹤0.01%
16,215
+862
+6% +$20K
RRBI icon
2578
Red River Bancshares
RRBI
$659M
$335K ﹤0.01%
6,957
+182
+3% +$9.01K
ERAS icon
2579
Erasca
ERAS
$6.39B
$334K ﹤0.01%
110,826
+13,248
+14% +$48.2K
INBK icon
2580
First Internet Bancorp
INBK
$255M
$332K ﹤0.01%
19,936
+294
+1% +$7.09K
NBN icon
2581
Northeast Bank
NBN
$1.14B
$330K ﹤0.01%
9,802
+45
+0.5% +$1.9K
BWB icon
2582
Bridgewater Bancshares
BWB
$603M
$329K ﹤0.01%
30,326
+494
+2% +$7.26K
SMR icon
2583
NuScale Power
SMR
$4.03B
$329K ﹤0.01%
36,225
-3,146
-8% -$31.6K
VUZI icon
2584
Vuzix
VUZI
$224M
$327K ﹤0.01%
79,098
+2,757
+4% +$12.4K
KNTE
2585
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$327K ﹤0.01%
52,373
+6,328
+14% +$38.6K
JANX icon
2586
Janux Therapeutics
JANX
$967M
$325K ﹤0.01%
26,849
+1,158
+5% +$19.3K
OPRX icon
2587
OptimizeRx
OPRX
$133M
$324K ﹤0.01%
22,114
-26,340
-54% -$441K
SCU
2588
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$324K ﹤0.01%
37,613
+605
+2% +$5.43K
BCML icon
2589
BayCom
BCML
$333M
$323K ﹤0.01%
18,896
+316
+2% +$6.06K
ACDC icon
2590
ProFrac Holding
ACDC
$787M
$322K ﹤0.01%
25,431
-809
-3% -$15.7K
GBIO
2591
DELISTED
Generation Bio
GBIO
$322K ﹤0.01%
7,491
+58
+0.8% +$2.81K
UTI icon
2592
Universal Technical Institute
UTI
$1.59B
$322K ﹤0.01%
43,698
+2,306
+6% +$16.4K
LEGH icon
2593
Legacy Housing
LEGH
$694M
$321K ﹤0.01%
14,085
-132
-0.9% -$2.67K
INO icon
2594
Inovio Pharmaceuticals
INO
$69M
$320K ﹤0.01%
32,487
+1,487
+5% +$25.3K
VLGEA icon
2595
Village Super Market
VLGEA
$639M
$318K ﹤0.01%
13,896
-161
-1% -$3.69K
NETI
2596
DELISTED
Eneti Inc.
NETI
$318K ﹤0.01%
34,022
+29
+0.1% +$290
QUAD icon
2597
Quad
QUAD
$525M
$316K ﹤0.01%
73,552
+300
+0.4% +$1.32K
TSP
2598
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
$315K ﹤0.01%
214,082
+4,128
+2% +$7.81K
RM icon
2599
Regional Management Corp
RM
$303M
$314K ﹤0.01%
12,051
+144
+1% +$4.46K
TRUE
2600
DELISTED
TrueCar
TRUE
$314K ﹤0.01%
136,586
+294
+0.2% +$784

Similar funds

RhumbLine Advisers's Q1 2023 Portfolio in Review

As of Q1 2023, RhumbLine Advisers held 3,027 positions worth $81B, up 9% from $74.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 2.6%. RhumbLine Advisers opened 17 new positions and exited 62, leaving the 3,027-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • RhumbLine Advisers's largest Q1 2023 buy was GE HealthCare: 633,417 shares worth $52M.
  • RhumbLine Advisers added most to Apple in Q1 2023, an estimated $164M increase.
  • RhumbLine Advisers's biggest Q1 2023 reduction was GE Aerospace, cutting an estimated $33M.
  • RhumbLine Advisers fully exited STORE Capital Corporation in Q1 2023, selling an estimated $26.2M.
  • RhumbLine Advisers's ten largest holdings make up 22% of its $81B portfolio in Q1 2023.
  • RhumbLine Advisers opened 17 new positions and closed 62 in Q1 2023.
  • RhumbLine Advisers's portfolio value rose 9% quarter-over-quarter to $81B.

Based on RhumbLine Advisers's 13F filing for Q1 2023, filed 11 May 2023.